Search results
Regardless, the seven-level, modified Rankin Scale (mRS) has several major strengths: it covers the entire range of functional outcomes from no symptoms to death, its categories are intuitive and easily grasped by both clinicians and patients, its concurrent validity is demonstrated by strong correlation with measures of stroke pathology (for ...
Jul 29, 2021 · The modified Rankin Scale (mRS) is a clinician-reported measure of global disability. The mRS serves a uniquely important role in stroke trial investigation and stroke clinical care.
Modified Rankin Scale for Neurologic Disability Measures the degree of disability or dependence in the daily activities of people who have suffered a stroke or other causes of neurological disability.
The Modified Rankin Scale (MRS) is a single item, global outcomes rating scale for patients post-stroke. It is used to categorize level of functional independence with reference to pre-stroke activities. rather than on observed performance of a specific task. Available versions.
Prognosis". Scott Med J 2 (5): 200–15. Patel, N., et al. Simple and reliable determination of the modified Rankin Scale in neurosurgical and neurological patients: The mRS-9Q. Neurosurgery, published online in advance of print 26 July 2012.
Apr 4, 2024 · This cross-sectional single-centre study aimed to investigate the relationship between stroke severity as measured by modified National Institutes of Health Stroke Scale (mNIHSS) and modified Rankin Scale (mRS) and factors affecting them.
The modified Rankin Scale (mRS) is a commonly used scale for measuring the degree of disability or dependence in the daily activities of people who have suffered a stroke or other causes of neurological disability.
Mar 20, 2016 · The modified Rankin Scale (mRS) is a 7-level ordered categorical scale capturing levels of patient functional independence following a stroke, with scores ranging from 0 (fully independent) to 6 (dead) [ 1 ].
The modified Rankin Scale (mRS) is a 7-level ordinal categorical scale capturing levels of patient functional independence following a stroke. The scale was initially described by Rankin in 1957 to assess the outcome of cerebrovascular accidents and slightly modified in 1988 [40].
Feb 1, 2007 · The modified Rankin Scale (mRS) is a clinician-reported measure of global disability that has been widely applied for evaluating recovery from stroke 1,2 and as a primary end point in randomized clinical trials (RCTs) of emerging acute stroke treatments. 3 The value of the mRS as a RCT end point has been examined in several investigations ...
